Select Publications
Journal articles
2019, 'Children's interstitial and diffuse lung disease', The Lancet Child and Adolescent Health, 3, pp. 568 - 577, http://dx.doi.org/10.1016/S2352-4642(19)30117-8
,2019, 'Distress during airway sampling in children with cystic fibrosis', Archives of Disease in Childhood, 104, pp. 806 - 808, http://dx.doi.org/10.1136/archdischild-2017-314241
,2019, 'Impact of influenza on hospitalization rates in children with a range of chronic lung diseases', Influenza and other Respiratory Viruses, 13, pp. 233 - 239, http://dx.doi.org/10.1111/irv.12633
,2019, 'Quantitative assessment of nocturnal neural respiratory drive in children with and without obstructive sleep apnoea using surface EMG', Experimental Physiology, 104, pp. 755 - 764, http://dx.doi.org/10.1113/EP087441
,2019, 'Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children', BMC Pulmonary Medicine, 19, pp. 71, http://dx.doi.org/10.1186/s12890-019-0835-5
,2019, 'Antibiotics for prolonged wet cough in children', Journal of Paediatrics and Child Health, 55, pp. 110 - 113, http://dx.doi.org/10.1111/jpc.14300
,2019, 'Clinical indicators for common paediatric conditions: Processes, provenance and products of the CareTrack Kids study', PLoS ONE, 14, pp. e0209637, http://dx.doi.org/10.1371/journal.pone.0209637
,2019, 'The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: A case-control study', Thorax, 74, pp. 261 - 269, http://dx.doi.org/10.1136/thoraxjnl-2018-212096
,2019, '1139 – The Intestinal Virome in Children with Cystic Fibrosis: A Pilot Study', Gastroenterology, 156, pp. S - 241, http://dx.doi.org/10.1016/s0016-5085(19)37406-2
,2019, 'Mo1947 – Taxonomic and Functional Intestinal Dysbiosis in Children with Cystic Fibrosis', Gastroenterology, 156, pp. S - 895, http://dx.doi.org/10.1016/s0016-5085(19)39210-8
,2019, 'Tu1872 – The Human Intestinal Proteome in Children with Cystic Fibrosis', Gastroenterology, 156, pp. S - 1153, http://dx.doi.org/10.1016/s0016-5085(19)39855-5
,2018, 'Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine', Frontiers in Pharmacology, 9, pp. 1429, http://dx.doi.org/10.3389/fphar.2018.01429
,2018, 'The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration', European Respiratory Journal, 52, http://dx.doi.org/10.1183/13993003.01855-2018
,2018, 'Research priorities for childhood chronic conditions: a workshop report.', Archives of Disease in Childhood, pp. 1 - 9, http://dx.doi.org/10.1136/archdischild-2018-315628
,2018, 'Research priority setting in childhood chronic disease: A systematic review', Archives of Disease in Childhood, 103, pp. 942 - 951, http://dx.doi.org/10.1136/archdischild-2017-314631
,2018, 'The School Experiences of Siblings of Children with Chronic Illness: Australian Parents' Perceptions', Educational and Developmental Psychologist, 35, pp. 36 - 50, http://dx.doi.org/10.1017/edp.2018.3
,2018, 'Quality of health care for children in Australia, 2012-2013', JAMA - Journal of the American Medical Association, 319, pp. 1113 - 1124, http://dx.doi.org/10.1001/jama.2018.0162
,2018, 'Protective factors for social-emotional well-being of refugee children in the first three years of settlement in Australia', Archives of Disease in Childhood, 103, pp. 261 - 268, http://dx.doi.org/10.1136/archdischild-2016-312495
,2018, 'Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: A case-control study protocol', BMJ Open, 8, pp. e020646, http://dx.doi.org/10.1136/bmjopen-2017-020646
,2018, 'Probiotics for people with cystic fibrosis', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD012949
,2018, 'Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10 years old', Journal of Cystic Fibrosis, 17, pp. 109 - 113, http://dx.doi.org/10.1016/j.jcf.2017.07.011
,2018, 'EPS4.04 Characterising the intestinal virome in cystic fibrosis', Journal of Cystic Fibrosis, 17, pp. S44 - S44, http://dx.doi.org/10.1016/s1569-1993(18)30256-x
,2018, 'P071 Predicting the functional intestinal profiles in cystic fibrosis', Journal of Cystic Fibrosis, 17, pp. S79 - S79, http://dx.doi.org/10.1016/s1569-1993(18)30368-0
,2017, 'Helping refugee children thrive: what we know and where to next.', Arch Dis Child, 103, pp. 529 - 532, http://dx.doi.org/10.1136/archdischild-2017-314055
,2017, 'Association between respiratory syncytial viral disease and the subsequent risk of the first episode of severe asthma in different subgroups of high-risk Australian children: A whole-of-population-based cohort study', BMJ Open, 7, pp. e017936, http://dx.doi.org/10.1136/bmjopen-2017-017936
,2017, 'Attentional Bias in Children with Asthma with and without Anxiety Disorders', Journal of Abnormal Child Psychology, 45, pp. 1635 - 1646, http://dx.doi.org/10.1007/s10802-017-0261-1
,2017, 'Parent-child interactions in children with asthma and anxiety', Behaviour Research and Therapy, 97, pp. 242 - 251, http://dx.doi.org/10.1016/j.brat.2017.08.010
,2017, 'Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children', Journal of Cystic Fibrosis, 16, pp. 631 - 636, http://dx.doi.org/10.1016/j.jcf.2017.03.010
,2017, 'Anxiety in youth with asthma: A meta-analysis', Pediatric Pulmonology, 52, pp. 1121 - 1129, http://dx.doi.org/10.1002/ppul.23689
,2017, 'Increased doses of inhaled corticosteroids during home management of asthma flare-ups do not reduce the need for systemic steroids', Journal of Paediatrics and Child Health, 53, pp. 915 - 917, http://dx.doi.org/10.1111/jpc.13680
,2017, 'Rare disease registries: a call to action', Internal Medicine Journal, 47, pp. 1075 - 1079, http://dx.doi.org/10.1111/imj.13528
,2017, 'Association of rhinovirus with exacerbations in young children affected by cystic fibrosis: Preliminary data', Journal of Medical Virology, 89, pp. 1494 - 1497, http://dx.doi.org/10.1002/jmv.24794
,2017, 'Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade's experience', ORPHANET JOURNAL OF RARE DISEASES, 12, http://dx.doi.org/10.1186/s13023-017-0637-x
,2017, 'Long-Term Pulmonary Morbidity of Respiratory Viral Infections During Chemotherapy in Children with Leukemia', PEDIATRIC BLOOD & CANCER, 64, pp. S31 - S31
,2017, 'Validation of a quantitative method to measure neural respiratory drive in children during sleep', Respiratory Physiology and Neurobiology, 239, pp. 75 - 80, http://dx.doi.org/10.1016/j.resp.2017.02.004
,2017, 'A case series evaluation of a pilot group cognitive behavioural treatment for children with asthma and anxiety', Behaviour Change, 34, pp. 35 - 47, http://dx.doi.org/10.1017/bec.2017.3
,2017, 'Infant feeding practices and diarrhoea in sub-Saharan African countries with high diarrhoea mortality', PLoS ONE, 12, pp. e0171792, http://dx.doi.org/10.1371/journal.pone.0171792
,2017, 'Threat interpretation and parental influences for children with asthma and anxiety', Behaviour Research and Therapy, 89, pp. 14 - 23, http://dx.doi.org/10.1016/j.brat.2016.11.004
,2017, 'Age-Dependent Values of Fecal Calprotectin in Cystic Fibrosis and Healthy Controls', Gastroenterology, 152, pp. S645 - S645, http://dx.doi.org/10.1016/s0016-5085(17)32281-3
,2017, 'Determining the Age-Related Levels of Fecal M2-Pyruvate Kinase in Children with Cystic Fibrosis During the First Decade of Life', Gastroenterology, 152, pp. S645 - S646, http://dx.doi.org/10.1016/s0016-5085(17)32282-5
,2017, 'EPS3.1 Age-dependent values of fecal calprotectin in cystic fibrosis and healthy children', Journal of Cystic Fibrosis, 16, pp. S41 - S41, http://dx.doi.org/10.1016/s1569-1993(17)30292-8
,2017, 'WS21.1 Determining the age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis during the first decade of life', Journal of Cystic Fibrosis, 16, pp. S34 - S34, http://dx.doi.org/10.1016/s1569-1993(17)30268-0
,2016, 'Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria', Clinical and Experimental Allergy, 46, pp. 1407 - 1415, http://dx.doi.org/10.1111/cea.12774
,2016, 'Persistent growth effects of inhaled corticosteroids', Journal of Paediatrics and Child Health, 52, pp. 964 - 966, http://dx.doi.org/10.1111/jpc.13356
,2016, 'CPAP can improve respiratory effort as measured by surface electromyogram of the diaphragm (sEMGdi) in children with sleep-disordered breathing', EUROPEAN RESPIRATORY JOURNAL, 48, http://dx.doi.org/10.1183/13993003.congress-2016.PA4351
,2016, 'Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry', Internal Medicine Journal, 46, pp. 1054 - 1062, http://dx.doi.org/10.1111/imj.13166
,2016, 'Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry', INTERNAL MEDICINE JOURNAL, 46, pp. 1054 - 1062, http://dx.doi.org/10.1111/imj.13166
,2016, 'Is there a role for stool metabolomics in cystic fibrosis?', Pediatrics International, 58, pp. 808 - 811, http://dx.doi.org/10.1111/ped.13063
,2016, 'Diagnosing cystic fibrosis-related diabetes: current methods and challenges', Expert Review of Respiratory Medicine, 10, pp. 799 - 811, http://dx.doi.org/10.1080/17476348.2016.1190646
,2016, 'A population study of respiratory rehospitalisation in very preterm infants in the first 3 years of life', Journal of Paediatrics and Child Health, 52, pp. 715 - 721, http://dx.doi.org/10.1111/jpc.13205
,